1. The number of patients who have been treated with Paxlovid (nirmatrelvir with ritonavir) in your Trust during the period 1st January 2022 to 31st July 2002.
2. The number of courses of Paxlovid (i.e. boxes of 20 nirmatrelvir and 10 ritonavir tablets) you had in stock on 1st August 2022.
